Cargando…
Role of laboratory biomarkers in assessing the severity of COVID-19 disease. A cross-sectional study
BACKGROUND: Corona virus disease 2019 (Covid-19) has high infectivity and mortality rate. Covid-19 patients can suddenly deteriorate and develop life threatening complications. Hence, there is a need to identify laboratory biomarkers in order to categorize high risk patients. The main purpose of the...
Autores principales: | Nizami, Deba J., Raman, Vidya, Paulose, L., Hazari, Komal S., Mallick, Ayaz K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284239/ https://www.ncbi.nlm.nih.gov/pubmed/34322414 http://dx.doi.org/10.4103/jfmpc.jfmpc_145_21 |
Ejemplares similares
-
Maternal and Fetal Outcome in Pregnant Women With Critical COVID-19 Treated With Tocilizumab in a Tertiary Care Hospital in Dubai
por: Isaac, Bindu, et al.
Publicado: (2023) -
Influence of laboratory biomarkers on inflammatory indices for assessing severity progression in COVID-19 cases
por: Prasad, Shrishtidhar, et al.
Publicado: (2022) -
Laboratory biomarkers associated with COVID-19 severity and management
por: Keddie, S., et al.
Publicado: (2020) -
Covid-19 infection in pregnant women in Dubai: a case-control study
por: Hazari, Komal Sundeep, et al.
Publicado: (2021) -
Laboratory Biomarkers Predicting COVID-19 Severity in the Emergency Room
por: Assandri, Roberto, et al.
Publicado: (2020)